Skip to main content

Ethomix

ethomix.com leverages AI and wearable technology to transform patient monitoring across clinical trials, drug development, and in-ward care. The company analyzes natural movement data captured from wearables to discover digital biomarkers, enabling faster, more sensitive, and more accurate patient assessments. Their platform is backed by a 50-terabyte repository of daily-life behavioral data and has been validated in peer-reviewed publications.

London, United Kingdom · HQ
2100+ followers
  • Artificial Intelligence
  • Digital Health
  • Drug Discovery & Therapeutics
  • Hardware
  • Healthcare Technology
  • Medical Devices
  • Software Only
Updated 10 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional patient monitoring in clinical trials and hospital settings relies on sporadic, subjective assessments that fail to capture the full picture of a patient's condition. This approach often leads to delayed detection of deterioration, requires larger cohort sizes to achieve statistical significance, and extends trial timelines, ultimately slowing down the delivery of new treatments to patients.

Solution

ethomix.com provides a comprehensive platform that uses AI and wearable technology to monitor patients continuously in their daily lives. The company captures movement data from wearables and remote sensing, then applies state-of-the-art machine learning to discover and validate digital biomarkers. This enables more precise and sensitive patient monitoring, which can dramatically reduce clinical trial cohort sizes and trial length while also providing 24/7 attention to patient state in hospital and home care settings. The platform offers a complete package for remote monitoring, supporting both clinical trials and ongoing patient care with higher precision and broader coverage than traditional methods.

Target Audience

Primary customers are pharmaceutical companies running clinical trials, healthcare providers monitoring patients in hospital wards, and home care organizations supporting assisted living environments.

Features

  • AI-powered digital biomarker discovery from wearable and human movement data
  • 50 terabyte repository of daily-life natural behavioral data for model training
  • International patents covering digital biomarkers and medical device technology
  • Validated technology with publications in Nature Medicine
  • Remote monitoring capabilities supporting 24/7 patient state assessment
  • Application across drug development, clinical trials, in-ward monitoring, and assisted living
This profile is AI-generated and may contain inaccuracies.